Sample size and power training for use in clinical trials

Webinar

Choosing the right sample size method

Rules for what will work for your study

This webinar has taken place.
The recording is now available

About the webinar

Choosing the Right Sample Size Method:
Rules for What will Work for your Study

For any given study there will be a wide variety of possible sample size methods available and selecting the correct sample size method for their study is one of the most common issues raised by researchers.

To solve this question, it is useful to have basic rules for selecting between the different tests, assumptions and sample size algorithms that may exist for your study. From dealing with selecting the best tests for the comparison of proportions to thinking about how to model non-proportional hazards in survival analysis, it is important to ensure your study plan and its sample size justification reflect the realities of your trial to ensure sufficient power.

In this webinar, we:

  • Explore some useful heuristics for selecting sample size methods.
  • Look at some case studies of where researchers have a variety of possible sample size options available for their study.

In this free webinar you will learn about

Proportions Options

The analysis of proportions is one of the most common endpoints in clinical trials. However, there is a wide variety of parameterisations and statistical tests to choose from. In this webinar, we assess the potential options available and some useful guidance on when given tests may be most appropriate.

Flexible Survival Analysis

Survival analysis is one of the most common statistical areas in oncology. For planning purposes, the primary interest is in predicting the required number of events for the targeted power. In survival analysis, we often also estimate the number of subjects needed to achieve that number of events and can do so while integrating significant flexibility to deal with the intrinsic uncertainty when dealing with the time to event endpoint. In this webinar, we display some of the flexibility available to model survival analysis when calculating the appropriate sample size.

Non-proportional Hazards

Non-proportional hazards and complex survival curves have become of increasing interest, due to being commonly seen in immunotherapy development. This has led to interest in assessing the robustness of standard methods and alternative methods that better adapt to deviations. In this webinar, we will look at methods proposed for complex survival curves and the weighted log-rank test as a candidate model to deal with a delayed survival effect.

Duration - 60 minutes

Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols


This webinar has taken place, you can watch the recording on our blog here.

Watch Now

All info submitted is secure. View our privacy policy.


About Our Host
Ronan Fitzpatrick

Ronan Fitzpatrick - nQuery Head of Statistics - Circle Image
Ronan Fitzpatrick is Head of Statistics at Statsols and the Lead Researcher for nQuery Sample Size Software. He has been a guest lecturer for many institutions including the FDA.
Reducing the risk & cost of clinical trials, for innovative organizations such as:
Sanofi-updated-grey
worldwide-clinical-trials
Covance-G_Logo
quintiles_logo_2017_grey
FDA_G_Logo
AstellasG_Logo
celgene_logo_download
Boehringer_Ingelheim_Logo-png-updated
PRA_Health_Sciences
Astrazeneca logo
Amgen_G_Logo
Novartis_G_Logo
abbvie-logo-updated_tmp15240
Merck_GLogo
Biogen-updated-logo
Ipsen-logo-only
Eli_Lilly_and_Company-G_Logo
Is there someone in your network that would be interested in our webinar?
Share this page by clicking below.